Abstract
The safety, tolerability and efficacy
both in terms of prophylaxis and of the
therapy of bleeding episodes achievable
with Advate® enables us to issue an
overall favorable ethical judgment. It
is nonetheless advisable that decision
makers work towards the creation of
procedures of continuity in treatment
and towards global care for patients,
as well as towards guaranteeing equal
access to medicine for all patients.
| Lingua originale | English |
|---|---|
| pagine (da-a) | 97-102 |
| Numero di pagine | 6 |
| Rivista | Italian Journal of Public Health |
| Volume | 9 |
| Stato di pubblicazione | Pubblicato - 2012 |
Keywords
- Advate
- ethical considerations in HTA